Biotech Top Stocks - Celsion Corp (NASDAQ:CLSN), Gilead Sciences, Inc. (NASDAQ:GILD), Arena Pharmaceuticals (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS)

Scottsdale, AZ -- (SBWIRE) -- 02/04/2013 -- Celsion Corporation (NASDAQ:CLSN) shares went down sharply after it is reported that its phase III trials of product Thermodox for the treatment of hepatocellular carcinoma was not successful. While Celsion is developing Thermodox for a number of indications, investors are currently concerned that the real appliance behind the product's effectiveness is defective.

In the last trading session, Celsion Corporation (NASDAQ:CLSN) plunged -12.58% to close at $1.32 and its total traded volume was 17.59 million shares. CLSN has outstanding shares of 35.01 million with the total market cap of 46.22 million.

Will CLSN Bounce Back After Friday’s Sharp Sell off? Find Out Here

Gilead Sciences, Inc. (NASDAQ:GILD) will report its latest earnings on Monday, February 4, 2013. The average analyst guess is for profit of 45 cents per share, a drop of 2.2% from the company’s actual earnings for the year-ago quarter. Analysts forecast an upsurge of 10.5% in revenue from the year-earlier quarter to $2.43 billion.

In the last trading session, Gilead Sciences, Inc. (NASDAQ:GILD) reported the gain of +2.81% and closed at $40.56 with the overall traded volume of 13.03 million shares. Stock price 52 weeks high was $41.14 and 52 weeks low price was $21.91.

For How Long GILD will Fight for Profitability? Read This Trend Analysis report

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares surged +1.54% with the closing price of $8.58. The overall volume in the last trading session was 5.81 million shares. Its fifty two week range was $1.70-$13.50. The total market capitalization remained $1.86 billion.

ARNA is ahead its 52 week low with 404.71% and its last month price volatility remained 4.19%. Its beta coefficient was 0.16 with a target price of $9.17. In its share capital ARNA has 217.29 million outstanding shares while 215.68 million shares have been floated in market. ARNA has insider ownership of 0.51% with its institutional ownership remained 45.57%. Company’s current year earnings per share grew with 29.52%.

Will ARNA Continue To Move Higher? Find Out Here

VIVUS, Inc. (NASDAQ:VVUS) gained +2.64% and closed at $12.43 in the last trading session and its total traded volume was 5.44 million shares more than the average volume of 5.03 million. VVUS has market cap of 1.25 billion and its beta value stands at 1.20 times.

Why Should Investors Buy VVUS After The Recent Gain? Just Go Here and Find Out

About Universal Penny Stocks
Universalpennystocks.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.

We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.